<?xml version="1.0" ?>
<tei xml:space="preserve">
	<teiHeader>
		<fileDesc xml:id="test4"/>
	</teiHeader>
	<text xml:lang="en">
		<front>

	<note type="doctype">ARTICLE OPEN<lb/></note>

	<docTitle>
	<titlePart>Suppression of FOXM1 activities and breast cancer growth<lb/> in vitro and in vivo by a new class of compounds<lb/></titlePart>
	</docTitle>

	<byline>
	<docAuthor>Yvonne Ziegler 1 , Mary J. Laws 1 , Valeria Sanabria Guillen 1 , Sung Hoon Kim 2 , Parama Dey 1 , Brandi P. Smith 3 , Ping Gong 1 ,<lb/> Noah Bindman 2 , Yuechao Zhao 1 , Kathryn Carlson 2 , Mayuri A. Yasuda 1 , Divya Singh 1 , Zhong Li 4 , Dorraya El-Ashry 5 ,<lb/> Zeynep Madak-Erdogan 3 , John A. Katzenellenbogen 2 and Benita S. Katzenellenbogen 1 *<lb/></docAuthor>
	</byline>

	<div type="abstract">The transcription factor FOXM1 is upregulated and overexpressed in aggressive, therapy-resistant forms of hormone receptor-<lb/>positive and triple negative breast cancers, and is associated with less good patient survival. FOXM1 signaling is also a key driver in<lb/> many other cancers. Here, we identify a new class of compounds effective in suppressing FOXM1 activity in breast cancers, and<lb/> displaying good potency for antitumor efficacy. The compounds bind directly to FOXM1 and alter its proteolytic sensitivity, reduce<lb/> the cellular level of FOXM1 protein by a proteasome-dependent process, and suppress breast cancer cell proliferation and cell cycle<lb/> progression and increase apoptosis. RNA-seq and gene set enrichment analyses indicate that the compounds decrease expression<lb/> of FOXM1-regulated genes and suppress gene ontologies under FOXM1 regulation. Several compounds have favorable<lb/> pharmacokinetic properties and show good tumor suppression in preclinical breast tumor models. These compounds may be<lb/> suitable for further clinical evaluation in targeting aggressive breast cancers driven by FOXM1.<lb/></div>

	<reference>npj Breast Cancer (2019) 5:45 ; </reference>

	<idno>https://doi.org/10.1038/s41523-019-0141-7</idno>

	<byline>
	<affiliation>1<lb/> Departments of Molecular and Integrative Physiology,</affiliation>
	</byline>

	<address>Urbana, IL 61801, USA.</address>

	<byline>
	<affiliation>2 Chemistry,</affiliation>
	</byline>

	<address>Urbana, IL 61801, USA.</address>

	<byline>
	<affiliation>3 Illinois Informatics Institute and Department of Food Science<lb/> and Human Nutrition,</affiliation>
	</byline>

	<address>Urbana, IL 61801, USA.</address>

	<byline>
	<affiliation>4 Metabolomics Center of the Roy J. Carver Biotechnology Center, University of Illinois at Urbana-Champaign,</affiliation>
	</byline>

	<address>Urbana, IL 61801, USA.</address>

	<byline>
	<affiliation>5<lb/> Department of Laboratory Medicine and Pathology, University of Minnesota Medical School,</affiliation>
	</byline>

	<address>Minneapolis, MN 55455, USA.</address>

	*email:
	<email>katzenel@illinois.edu<lb/></email>

	www.nature.com/npjbcancer<lb/> Published in partnership with the Breast Cancer Research Foundation<lb/> 1234567890():,;<lb/>
	<note type="submission">Received: 13 February 2019; Accepted: 8 November 2019;<lb/></note>

	<note type="copyright">Open Access This article is licensed under a Creative Commons<lb/> Attribution 4.0 International License, which permits use, sharing,<lb/> adaptation, distribution and reproduction in any medium or format, as long as you give<lb/> appropriate credit to the original author(s) and the source, provide a link to the Creative<lb/> Commons license, and indicate if changes were made. The images or other third party<lb/> material in this article are included in the article&apos;s Creative Commons license, unless<lb/> indicated otherwise in a credit line to the material. If material is not included in the<lb/> article&apos;s Creative Commons license and your intended use is not permitted by statutory<lb/> regulation or exceeds the permitted use, you will need to obtain permission directly<lb/> from the copyright holder. To view a copy of this license, visit http://creativecommons.<lb/> org/licenses/by/4.0/.<lb/>Â© The Author(s) 2019</note>

		</front>
	</text>
</tei>
